tradingkey.logo
tradingkey.logo
Search

Climb Bio Inc

CLYM
Add to Watchlist
12.100USD
+0.200+1.68%
Close 07-31 16:00ETQuotes delayed by 15 min
825.03MMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
RA Capital Management, LP
19.74%
Pontifax Venture Capital
9.09%
MPM BioImpact LLC
4.67%
T. Rowe Price Associates, Inc.
3.36%
Adar1 Capital Management LLC
2.50%
Other
60.64%
Shareholders
Shareholders
Proportion
RA Capital Management, LP
19.74%
Pontifax Venture Capital
9.09%
MPM BioImpact LLC
4.67%
T. Rowe Price Associates, Inc.
3.36%
Adar1 Capital Management LLC
2.50%
Other
60.64%
Shareholder Types
Shareholders
Proportion
Venture Capital
28.89%
Hedge Fund
14.53%
Investment Advisor
10.51%
Investment Advisor/Hedge Fund
7.74%
Research Firm
1.03%
Individual Investor
0.39%
Pension Fund
0.15%
Other
36.77%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
194
35.98M
59.67%
-6.59M
2025Q4
180
50.12M
94.21%
+7.08K
2025Q3
182
50.11M
95.00%
-5.30M
2025Q2
174
55.41M
95.70%
-2.05M
2025Q1
161
57.46M
90.60%
-8.97M
2024Q4
149
56.10M
86.82%
+979.54K
2024Q3
120
56.83M
81.50%
+4.66M
2024Q2
84
51.93M
31.41%
+31.40M
2024Q1
82
18.86M
80.37%
-3.42M
2023Q4
86
18.86M
80.98%
+125.11K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
RA Capital Management, LP
11.30M
23.66%
+7.11K
+0.06%
Jan 05, 2026
Pontifax Venture Capital
5.21M
10.9%
--
--
Mar 31, 2025
MPM BioImpact LLC
2.67M
5.59%
+2.67M
--
Dec 31, 2025
T. Rowe Price Associates, Inc.
1.92M
4.03%
+1.40M
+265.07%
Dec 31, 2025
Adar1 Capital Management LLC
1.43M
3%
+1.30M
+972.77%
Dec 31, 2025
Affinity Asset Advisors LLC
1.30M
2.72%
--
--
Dec 31, 2025
Kynam Capital Management LP
1.03M
2.15%
--
--
Dec 31, 2025
Great Point Partners, LLC
979.53K
2.05%
+979.53K
--
Dec 31, 2025
Sphera Funds Management Ltd.
932.25K
1.95%
+497.41K
+114.39%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ProShares Ultra Nasdaq Biotechnology
0.01%
iShares Biotechnology ETF
0.01%
Invesco Nasdaq Biotechnology ETF
0.01%
iShares Micro-Cap ETF
0.01%
Avantis US Small Cap Equity ETF
0%
iShares Russell 2000 Growth ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Neuroscience and Healthcare ETF
0%
iShares Russell 2000 Value ETF
0%
View more
ProShares Ultra Nasdaq Biotechnology
Proportion0.01%
iShares Biotechnology ETF
Proportion0.01%
Invesco Nasdaq Biotechnology ETF
Proportion0.01%
iShares Micro-Cap ETF
Proportion0.01%
Avantis US Small Cap Equity ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
iShares Neuroscience and Healthcare ETF
Proportion0%
iShares Russell 2000 Value ETF
Proportion0%
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.